rs61729354
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018076.5(ODAD2):c.612T>A(p.Asp204Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,613,588 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_018076.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD2 | NM_018076.5 | c.612T>A | p.Asp204Glu | missense_variant | 5/20 | ENST00000305242.10 | NP_060546.2 | |
LOC112268060 | XR_002957065.1 | n.86+973A>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD2 | ENST00000305242.10 | c.612T>A | p.Asp204Glu | missense_variant | 5/20 | 1 | NM_018076.5 | ENSP00000306410 | P1 | |
ODAD2 | ENST00000673439.1 | c.612T>A | p.Asp204Glu | missense_variant | 5/20 | ENSP00000500782 | P1 | |||
ODAD2 | ENST00000434029.1 | n.294T>A | non_coding_transcript_exon_variant | 3/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00557 AC: 847AN: 152186Hom.: 10 Cov.: 32
GnomAD3 exomes AF: 0.00156 AC: 393AN: 251168Hom.: 4 AF XY: 0.00122 AC XY: 165AN XY: 135760
GnomAD4 exome AF: 0.000798 AC: 1166AN: 1461284Hom.: 8 Cov.: 30 AF XY: 0.000732 AC XY: 532AN XY: 726990
GnomAD4 genome AF: 0.00560 AC: 853AN: 152304Hom.: 10 Cov.: 32 AF XY: 0.00514 AC XY: 383AN XY: 74476
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 23 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at